22nd Century Group Bolsters Marketing Leadership with Consumer Health Veteran
Event summary
- 22nd Century Group appointed Katherine Rouse-Bailey as Vice President of Marketing on July 16, 2026.
- Rouse-Bailey brings 20 years of consumer health and brand-building experience from Johnson & Johnson, Galderma, and Nestlé Health Science.
- The move is part of a broader strategy to drive VLN® brand awareness and support retail sell-through in H2 2026.
- VLN® cigarettes, FDA-authorized in December 2021, are the only combustible cigarettes approved for nicotine reduction.
The big picture
This appointment signals 22nd Century's shift from product development to aggressive market penetration, leveraging Rouse-Bailey's expertise in consumer health branding. The move comes as the company seeks to capitalize on FDA authorization for VLN® cigarettes, positioning itself as a leader in tobacco harm reduction. Success will depend on translating clinical validation into mainstream consumer adoption.
What we're watching
- Brand Momentum
- Whether Rouse-Bailey's data-driven approach can accelerate VLN®'s consumer trial and repeat purchase rates.
- Regulatory Tailwinds
- How FDA authorization of low-nicotine products will influence market adoption and competitive positioning.
- Execution Risk
- The pace at which 22nd Century can scale its marketing initiatives to match expanding commercial footprint.